Home › Trial NCT00525525
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
- Trial IDNCT00525525
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity of California, San Francisco
- Enrollment74
- Start date2007-09
- ConditionsGlioblastoma · Gliosarcoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.